Back to Top Skip to main content Skip to sub-navigation

NMCP unveils new COVID-19 testing system

A group of military health personnel, wearing masks, in front of a large machine with a red ribbon in front of it. Naval Medical Center Portsmouth (NMCP) Microbiology Department recently unveiled their new Panther system to help in the fight against the Coronavirus disease (COVID-19) and its operational impact. Members of NMCP's Laboratory joined Navy Capt. Lisa Mulligan, NMCP's commanding officer, and Navy Cmdr. Peter Carbone, NMCP's Laboratory department head (center), as they cut the ribbon marking the start of the use of the Panther system at NMCP. (Photo by Petty Officer 2nd Class Dylan Kinee, NMC Portsmouth.)

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Naval Medical Center Portsmouth (NMCP) Microbiology Department recently unveiled their new Panther system to help in the fight against the Coronavirus disease (COVID-19) and its operational impact.

The Panther system is a best-in-class, fully automated, sample-to-result platform. Each Panther system can provide initial results in approximately four hours, and it is able process around 1,000 COVID-19 tests in a 24-hour period.

“With this new system, at the end of the day, we spend the same amount of time testing but with three times the output volume,” said Ruben Ayala, an NMCP microbiologist who worked on getting the Panther system to the medical center. “We can do an even better job taking care of all our patients in-house and get the results a lot faster.”

Located in the Tidewater region, NMCP is the primary medical center for the region that hosts the largest U.S. military concentration in the world. Due to the ongoing pandemic, operational commands in the region are required to get COVID-19 tests before being cleared to execute operations or perform exercises. Now, NMCP will be able to support large groups requiring COVID tests in a shorter period of time.

“Any operational unit that needs to be cleared pre-deployment can come in at, say, seven o’clock (a.m.), and they’ll be deployed that afternoon if everything is negative,” Ayala said. “It’s perfect for operational readiness in concerns with COVID-19.”

Once NMCP’s Microbiology Department received all the supplies and equipment, they rallied together and were able to complete assembly of the Panther system ahead of schedule.

“From the lowest rank to the highest rank, everyone was doing their part for the team,” Ayala said. “They were mission focused at all times. We had a lot of regulations that we had to fulfill and everyone was cooperating and willing to fulfill those regulations in about three weeks. Everyone was willing to go the extra mile to get this done.”

“Robust testing and contact tracing are the foundation of any effective virus containment plan,” said Navy Capt. Melissa Austin, NMCP’s executive officer. “The Panther provides us with high-throughput diagnostic testing capability that will enable us to better support both the operational forces and clinical care here in the hospital.”

“COVID-19 is currently the sole focus for this machine,” said Sean Ehrsam, an NMCP medical laboratory technician. “But when COVID-19 testing slows down, we can open up the machine to other types of testing.”

“I am so proud of the team effort from our laboratory, facilities, and logistic departments to get the platform installed, validated, and supplied in such a short time,” added Austin.

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus
Showing results 1 - 12 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.